References
[1] WHO. World Health Organization. Coronavirus disease 2019
(COVID-19) situation report – 96 n.d.
[2] Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman
L, et al. Features of 20 133 UK patients in hospital with covid-19 using
the ISARIC WHO Clinical Characterisation Protocol: prospective
observational cohort study. BMJ 2020;369.
https://doi.org/10.1136/bmj.m1985.
[3] Bouzid D, Mulahert J, hingrat QL, Laurent odile, Duval X,
Lescure X, et al. Characteristics associated with COVID-19 or other
respiratory viruses’ infections at a single-center Emergency Department.
Preprints; 2020. https://doi.org/10.22541/au.160091431.15743661.
[4] Lai C-C, Wang C-Y, Hsueh P-R. Co-infections among patients with
COVID-19: The need for combination therapy with non-anti-SARS-CoV-2
agents? J Microbiol Immunol Infect 2020;53:505–12.
https://doi.org/10.1016/j.jmii.2020.05.013.
[5] Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of
Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA
2020. https://doi.org/10.1001/jama.2020.6266.
[6] Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people
with COVID-19: a systematic review and meta-analysis. J Infect
2020;81:266–75. https://doi.org/10.1016/j.jinf.2020.05.046.
[7] Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE. Coinfection
in SARS-CoV-2 infected patients: Where are influenza virus and
rhinovirus/enterovirus? J Med Virol 2020;92:1699–700.
https://doi.org/10.1002/jmv.25953.
[8] Visseaux B, Le Hingrat Q, Collin G, Bouzid D, Lebourgeois S, Le
Pluart D, et al. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2
Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2
detection. J Clin Microbiol 2020. https://doi.org/10.1128/JCM.00630-20.
[9] Leber AL, Everhart K, Daly JA, Hopper A, Harrington A,
Schreckenberger P, et al. Multicenter Evaluation of BioFire FilmArray
Respiratory Panel 2 for Detection of Viruses and Bacteria in
Nasopharyngeal Swab Samples. J Clin Microbiol 2018;56.
https://doi.org/10.1128/JCM.01945-17.
[10] Visseaux B, Le Hingrat Q, Collin G, Ferré V, Storto A, Ichou H,
et al. Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO
performances and limit of detection. Journal of Clinical Virology
2020;129:104520. https://doi.org/10.1016/j.jcv.2020.104520.
[11] Wirden M, Feghoul L, Bertine M, Nere M-L, Le Hingrat Q, Abdi B,
et al. Multicenter comparison of the Cobas 6800 system with the RealStar
RT-PCR kit for the detection of SARS-CoV-2. J Clin Virol
2020;130:104573. https://doi.org/10.1016/j.jcv.2020.104573.
[12] Visseaux B, Burdet C, Voiriot G, Lescure F-X, Chougar T,
Brugière O, et al. Prevalence of respiratory viruses among adults, by
season, age, respiratory tract region and type of medical unit in Paris,
France, from 2011 to 2016. PLoS One 2017;12.
https://doi.org/10.1371/journal.pone.0180888.
[13] Mandelia Y, Procop GW, Richter SS, Worley S, Liu W, Esper F.
Dynamics and predisposition of respiratory viral co-infections in
children and adults. Clinical Microbiology and Infection 2020;0.
https://doi.org/10.1016/j.cmi.2020.05.042.
[14] RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR,
Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with
Covid-19 - Preliminary Report. N Engl J Med 2020.
https://doi.org/10.1056/NEJMoa2021436.
[15] Zhang AJ, Lee AC-Y, Chan JF-W, Liu F, Li C, Chen Y, et al.
Co-infection by severe acute respiratory syndrome coronavirus 2 and
influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in
golden Syrian hamsters. Clin Infect Dis 2020.
https://doi.org/10.1093/cid/ciaa1747.